Investment consortium to buy Syneos Health in $7.1 bln deal
May 10 (Reuters) - An investment consortium, comprising of Elliott Investment Management, Patient Square Capital and Veritas Capital, has agreed to buy Syneos Health Inc SYNH.O , in a deal valued at $7.1 billion, including debt, the contract research firm said on Wednesday. (Reporting by Bhanvi Satija and Khushi Mandowara in Bengaluru; Editing by Shailesh Kuber) ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91 9873062788;))
Recent news on Syneos Health
See all newsHayward Holdings rises on S&P Smallcap 600 inclusion
Brief: Syneos Health And Oracle To Expand Partnership
Large LBO bond sales could prompt September US junk debt rush
Brief: SYNEOS HEALTH AND STAR PARENT ANNOUNCE PROPOSED $1.70 BILLION OFFERING OF SENIOR SECURED NOTES
Brief: Syneos Health Announces Agreement With Aotearoa Clinical Trials, Expanding Clinical Trial Capabilities Across Range Of Therapeutic Areas In New Zealand